NBE-Therapeutics Company
NBE-Therapeutics is a privately owned Swiss, Basel-based Biotech company that was founded in 2012 with the vision to develop next-generation ADCs improving treatment options for cancer patients. The company is financially backed by the Boehringer Ingelheim Venture Fund and additional private investors. NBE-Therapeutics GmbH engages in the development of antibody drug conjugates for the therapy of cancer.
Technology:
Prevention
Industry:
P3 Medicine
Headquarters:
Basel, Basel-Stadt, Switzerland
Founded Date:
2012
Employees Number:
Undisclosed
Funding Status:
Early Stage Venture
Register and Claim Ownership